Concepedia

Ashkan Shahbandi

AS

6

Publications

496

Citations

6

H-Index

2018

Active since

Affiliations

Tulane University(Current)

Ashkan Shahbandi is an author at Tulane University specializing in cancer therapeutics, breast cancer, and cell biology.

Top concepts

MedicineCell BiologyBreast CancerCancer TherapyOncologyImmunologyTumor BiologyCancer ResearchHealthAppetite

Publications per year

2018–2022

6

Publications

6

Chemotherapy-induced senescent cancer cells engulf other cells to enhance their survival

Crystal A. Tonnessen-Murray, Wesley D. Frey, Sonia G. Rao et al. · The Journal of Cell Biology · 2019 · 123 citations · Full text

Chemotherapy-treated Breast Cancer, Medicine, Immunology +15

BH3 mimetics selectively eliminate chemotherapy-induced senescent cells and improve response in TP53 wild-type breast cancer

Ashkan Shahbandi, Sonia G. Rao, Ashlyn Y. Anderson et al. · Cell Death and Differentiation · 2020 · 117 citations · Full text

Tumor Biology, Breast Oncology, Bh3 Mimetics +11

Breast cancer survival predicted by TP53 mutation status differs markedly depending on treatment

Nathan Ungerleider, Sonia G. Rao, Ashkan Shahbandi et al. · Breast Cancer Research · 2018 · 101 citations · Full text

Breast cancer cells survive chemotherapy by activating targetable immune-modulatory programs characterized by PD-L1 or CD80

Ashkan Shahbandi, Fang-Yen Chiu, Nathan Ungerleider et al. · Nature Cancer · 2022 · 74 citations · Full text

Breast Oncology, Cancer Immunosurveillance, Immunology +7

Analysis across multiple tumor types provides no evidence that mutant p53 exerts dominant negative activity

Ashkan Shahbandi, James G. Jackson · npj Precision Oncology · 2018 · 64 citations · Full text

Rows per page

1–5 of 6